My research interests fundamentally lie in drug development and cancer therapeutics. I am interested in applying computational approaches to improve the efficiency of the initial stages of development, as well as in understanding how point mutations can alter protein structure, which I believe can be exploited for the development of new and next-generation therapeutics. I chose Gerstner Sloan Kettering for graduate studies because it provides access to a phenomenal group of scientists and mentors — and because it was truly special to see how happy the graduate students were when I was interviewing! And New York City offers a huge number of opportunities. There is always something to do. If you have an interest, you can find something or somewhere to do it!